These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 19233498)

  • 1. Irregular facial scars treated with photoelectric therapy and triamcinolone acetonide injection packaging: a report of two cases.
    Eur J Dermatol; 2024 Apr; 34(2):225-226. PubMed ID: 38907566
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancing glycaemic control with impetus on weight management: Observing for early worsening of diabetic retinopathy.
    Jacob S; Varughese GI
    Eye (Lond); 2024 Jul; 38(10):1787-1788. PubMed ID: 38341496
    [No Abstract]   [Full Text] [Related]  

  • 3. Switching to subtenon triamcinolone acetonide does not jeopardize the functional and anatomic outcomes of dexamethasone implant treated eyes with diabetic macular edema.
    Borella Y; Bertaud S; Tadayoni R; Bodaghi B; Dupas B; Touhami S
    Graefes Arch Clin Exp Ophthalmol; 2024 Apr; ():. PubMed ID: 38668853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous glucose monitoring metrics following sub-Tenon's injection of triamcinolone acetonide for diabetic macular edema.
    Sotani-Ogawa R; Kusuhara S; Hirota Y; Kim KW; Matsumiya W; Ogawa W; Nakamura M
    Graefes Arch Clin Exp Ophthalmol; 2024 Feb; 262(2):449-456. PubMed ID: 37864636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal versus posterior subtenon injection of triamcinolone acetonide for diabetic macular edema.
    Choi YJ; Oh IK; Oh JR; Huh K
    Korean J Ophthalmol; 2006 Dec; 20(4):205-9. PubMed ID: 17302204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema.
    Salti H; Farah T
    Am J Ophthalmol; 2005 Nov; 140(5):958; author reply 958-9. PubMed ID: 16310498
    [No Abstract]   [Full Text] [Related]  

  • 7. Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema.
    Bakri SJ; Kaiser PK
    Am J Ophthalmol; 2005 Feb; 139(2):290-4. PubMed ID: 15733990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Posterior Subtenon Triamcinolone Acetonide Injection on Diabetic Macular Edema Refractory to Intravitreal Bevacizumab Injection.
    Kim MW; Moon H; Yang SJ; Joe SG
    Korean J Ophthalmol; 2016 Feb; 30(1):25-31. PubMed ID: 26865800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of posterior subtenon injection of 40 mg of triamcinolone acetonide on glycemic control and serum cortisol and adrenocorticotropic hormone in diabetic patients.
    Kaderli B; Kivanc SA; Inan UU; Ersoy C; Yucel AA; Yilmaz S; Avci R
    Eur Rev Med Pharmacol Sci; 2014; 18(18):2609-14. PubMed ID: 25317793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic complications of posterior subtenon injection of triamcinolone acetonide in type 2 diabetes patients.
    Toda J; Fukushima H; Kato S
    Diabetes Res Clin Pract; 2009 May; 84(2):e38-40. PubMed ID: 19233498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal versus subtenon triamcinolone acetonide injection for diabetic macular edema: a systematic review and meta-analysis.
    Qi HP; Bi S; Wei SQ; Cui H; Zhao JB
    Curr Eye Res; 2012 Dec; 37(12):1136-47. PubMed ID: 22793880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
    Jonas JB
    Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.